0001209191-19-010177.txt : 20190214
0001209191-19-010177.hdr.sgml : 20190214
20190214163305
ACCESSION NUMBER: 0001209191-19-010177
CONFORMED SUBMISSION TYPE: 5
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181231
FILED AS OF DATE: 20190214
DATE AS OF CHANGE: 20190214
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Tilton John
CENTRAL INDEX KEY: 0001704251
FILING VALUES:
FORM TYPE: 5
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38080
FILM NUMBER: 19607152
MAIL ADDRESS:
STREET 1: C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP
STREET 2: 234 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Biohaven Pharmaceutical Holding Co Ltd.
CENTRAL INDEX KEY: 0001689813
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D8
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 203-404-0410
MAIL ADDRESS:
STREET 1: 215 CHURCH STREET
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
5
1
doc5.xml
FORM 5 SUBMISSION
X0306
5
2018-12-31
0
0
1
0001689813
Biohaven Pharmaceutical Holding Co Ltd.
BHVN
0001704251
Tilton John
C/O BIOHAVEN PHARMACEUTICALS, INC.
215 CHURCH STREET
NEW HAVEN
CT
06510
0
1
0
0
Chief Commercial Officer
Stock Option (Right to Buy)
32.42
2018-11-20
4
A
0
L
30000
0.00
A
2028-11-19
Common Shares
30000
30000
D
The shares underlying this option vest in four equal installments on November 20, 2019, 2020, 2021 and 2022, subject to the reporting person's continuous service with the issuer at each vesting date.
/s/ Darren DeStefano, Attorney-in-Fact
2019-02-14